Latest filing published 15 Oct 2026 for Apotex Health Corp., €6,386.
Insider track record
Allan Grant Oberman: trading record in brief
Allan Grant Oberman discloses dealings in Apotex Health Corp. to SEDI. Over a trading history stretching from 9 June 2026 to 1 October 2026, the count stands at 10 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 15 October 2026: a share grant of €6,386, in Apotex Health Corp. Between a trade and the moment it shows up on SEDI, the median delay is 9 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Allan Grant Oberman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 321 shares@ CA$32.030.1% of flowDeferred Share UnitsTSXSEDI:4791446
- 532,062 shares@ CA$34.0099.9% of flowCommon SharesTSXSEDI:4779329
- Common SharesTSXSEDI:4779327
- 532,062 shares@ CA$0.010.0% of flowRestricted Share UnitsTSXSEDI:4779326
- 5,828 sharesDeferred Share UnitsTSXSEDI:4766159
- Deferred Share UnitsTSXSEDI:4766158
- Restricted Share UnitsTSXSEDI:4736942
- OptionsTSXSEDI:4736940
- Common SharesTSXSEDI:4736938
9 of 9 declarations